Intuitive Surgical, Inc. (NASDAQ:ISRG) Receives Average Recommendation of “Buy” from Analysts

Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) have been given a consensus recommendation of “Buy” by the eighteen research firms that are currently covering the firm, MarketBeat reports. Two analysts have rated the stock with a sell rating, five have issued a hold rating and eleven have issued a buy rating on the company. The average twelve-month target price among analysts that have covered the stock in the last year is $587.62.

Several equities analysts recently issued reports on the company. Morgan Stanley set a $620.00 price objective on Intuitive Surgical and gave the stock a “buy” rating in a report on Friday, October 18th. UBS Group lifted their price objective on Intuitive Surgical from $560.00 to $590.00 and gave the stock a “neutral” rating in a report on Friday, October 18th. Wells Fargo & Co set a $620.00 price objective on Intuitive Surgical and gave the stock a “buy” rating in a report on Friday, October 18th. Zacks Investment Research raised Intuitive Surgical from a “hold” rating to a “buy” rating and set a $601.00 price objective for the company in a report on Thursday, November 21st. Finally, Oppenheimer assumed coverage on Intuitive Surgical in a report on Wednesday, November 20th. They set a “market perform” rating for the company.

ISRG stock traded down $2.22 during midday trading on Friday, hitting $579.28. 2,006 shares of the stock were exchanged, compared to its average volume of 535,936. The stock’s 50-day moving average price is $550.63 and its 200-day moving average price is $520.57. The stock has a market cap of $65.82 billion, a price-to-earnings ratio of 61.28, a PEG ratio of 4.27 and a beta of 1.12. Intuitive Surgical has a fifty-two week low of $430.24 and a fifty-two week high of $589.32.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $3.43 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.99 by $0.44. The firm had revenue of $1.13 billion during the quarter, compared to analysts’ expectations of $1.06 billion. Intuitive Surgical had a return on equity of 18.26% and a net margin of 30.94%. Intuitive Surgical’s revenue was up 22.5% on a year-over-year basis. During the same period in the previous year, the firm posted $2.83 earnings per share. Analysts predict that Intuitive Surgical will post 10.96 EPS for the current fiscal year.

In other news, Director Lonnie M. Smith sold 205 shares of Intuitive Surgical stock in a transaction on Friday, November 8th. The stock was sold at an average price of $554.49, for a total value of $113,670.45. Following the completion of the sale, the director now owns 368,952 shares of the company’s stock, valued at $204,580,194.48. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Mark J. Rubash sold 1,000 shares of Intuitive Surgical stock in a transaction on Tuesday, November 19th. The shares were sold at an average price of $580.00, for a total value of $580,000.00. Following the completion of the sale, the director now directly owns 5,298 shares of the company’s stock, valued at approximately $3,072,840. The disclosure for this sale can be found here. In the last ninety days, insiders sold 13,897 shares of company stock valued at $7,627,990. Company insiders own 1.70% of the company’s stock.

Hedge funds have recently bought and sold shares of the business. ARK Investment Management LLC lifted its stake in shares of Intuitive Surgical by 10.3% during the second quarter. ARK Investment Management LLC now owns 5,434 shares of the medical equipment provider’s stock worth $2,850,000 after purchasing an additional 508 shares in the last quarter. Burns J W & Co. Inc. NY lifted its stake in shares of Intuitive Surgical by 28.2% during the second quarter. Burns J W & Co. Inc. NY now owns 1,497 shares of the medical equipment provider’s stock worth $785,000 after purchasing an additional 329 shares in the last quarter. Birinyi Associates Inc. acquired a new position in shares of Intuitive Surgical during the second quarter worth about $787,000. Bluestein R H & Co. lifted its stake in shares of Intuitive Surgical by 16.7% during the second quarter. Bluestein R H & Co. now owns 33,971 shares of the medical equipment provider’s stock worth $17,819,000 after purchasing an additional 4,861 shares in the last quarter. Finally, HCR Wealth Advisors lifted its stake in shares of Intuitive Surgical by 19.6% during the second quarter. HCR Wealth Advisors now owns 532 shares of the medical equipment provider’s stock worth $279,000 after purchasing an additional 87 shares in the last quarter. 85.59% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Its da Vinci Surgical System transforms the surgeon's natural hand movements outside the body into corresponding micro-movements inside the patient's body. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D vision systems, da Vinci skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures.

Featured Article: What does it mean to hold a stock in street name?

Analyst Recommendations for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.